Kolexia
Chaput-Gras Nathalie Pharmacien
Chaput-Gras Nathalie
Pharmacien
Gustave-Roussy
Villejuif, France
176 Activités
603 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire non à petites cellules Carcinome pulmonaire à petites cellules Mélanome Carcinomes Néphrocarcinome Colite Inflammation Métastase tumorale

Collaborateurs

Voir plus
Besse Benjamin
Besse Benjamin
Gustave-Roussy, Villejuif, France
Planchard David
Planchard David
Gustave-Roussy, Villejuif, France
Soria Jean-Charles
Soria Jean-Charles
Gustave-Roussy, Villejuif, France
Marabelle Aurelien
Marabelle Aurelien
Gustave-Roussy, Villejuif, France

Industries

Voir plus
AstraZeneca
4 collaboration(s)
Dernière en 2023
Servier
1 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study.
European journal of cancer (Oxford, England : 1990)   03 février 2024
23P Circulating immune cells and activity of immune checkpoint inhibitors in metastatic renal cell carcinoma
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8 T cells in patients with advanced NSCLC.
Science advances   08 novembre 2023
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
Frontiers in immunology   18 octobre 2023
1909P Baseline cytokine levels according to the line of treatment in patients with metastatic clear cell renal cell carcinoma treated with nivolumab: NIVOREN GETUG-AFU 26 translational study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
2300P Clonal hematopoiesis of indeterminate potential (CHIP) in patients with advanced NSCLC treated with immune checkpoint blockers (ICB) as monotherapy: Analysis of the PREMIS study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers.
Journal for immunotherapy of cancer   14 septembre 2023
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab.
Annals of oncology : official journal of the European Society for Medical Oncology   07 août 2023
PEMBIB: Phase Ib Trial Of Pembrolizumab And Nintedanib
Essai Clinique (Gustave-Roussy)   24 avril 2023